These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 39162231)
1. Contemporary treatment and outcome of sinonasal undifferentiated carcinoma: A meta-analysis. Burggraf M; Schiele S; Thölken R; López FJF; Elawany N; Zenk J; Doescher J Head Neck; 2024 Nov; 46(11):2890-2900. PubMed ID: 39162231 [TBL] [Abstract][Full Text] [Related]
2. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma. Kuo P; Manes RP; Schwam ZG; Judson BL Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092 [TBL] [Abstract][Full Text] [Related]
3. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review. Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248 [TBL] [Abstract][Full Text] [Related]
4. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival. Lehrich BM; Goshtasbi K; Abiri A; Yasaka T; Sahyouni R; Papagiannopoulos P; Tajudeen BA; Kuan EC Int Forum Allergy Rhinol; 2020 May; 10(5):679-688. PubMed ID: 32104985 [TBL] [Abstract][Full Text] [Related]
5. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review. Xu CC; Dziegielewski PT; McGaw WT; Seikaly H J Otolaryngol Head Neck Surg; 2013 Jan; 42(1):2. PubMed ID: 23663264 [TBL] [Abstract][Full Text] [Related]
6. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549 [TBL] [Abstract][Full Text] [Related]
7. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience. Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906 [TBL] [Abstract][Full Text] [Related]
8. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis. Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819 [TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy. van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis of multi-modality therapies in sinonasal undifferentiated carcinoma-A timely update. See ASY; Chu C; Lim ICZY; Tan BKJ; Ang SXQ; Xu S; Teo NWY; Charn TC Clin Otolaryngol; 2024 Jan; 49(1):29-40. PubMed ID: 37859617 [TBL] [Abstract][Full Text] [Related]
11. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621 [TBL] [Abstract][Full Text] [Related]
12. Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature. Al-Mamgani A; van Rooij P; Mehilal R; Tans L; Levendag PC Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):293-9. PubMed ID: 22476411 [TBL] [Abstract][Full Text] [Related]
13. Sinonasal Undifferentiated Carcinoma. Abdelmeguid AS; Bell D; Hanna EY Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study. de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059 [TBL] [Abstract][Full Text] [Related]
18. Sinonasal undifferentiated carcinoma: Institutional trend toward induction chemotherapy followed by definitive chemoradiation. London NR; Mohyeldin A; Daoud G; Gamez ME; Blakaj D; Bonomi M; Prevedello DM; Carrau RL Head Neck; 2020 Nov; 42(11):3197-3205. PubMed ID: 32681692 [TBL] [Abstract][Full Text] [Related]
19. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature. Zielinski V; Laban S; Tribius S; Schafhausen P; Veldhoen S; Knecht R; Clauditz T; Muenscher A Ear Nose Throat J; 2016 Jan; 95(1):23-8. PubMed ID: 26829682 [TBL] [Abstract][Full Text] [Related]
20. Sinonasal undifferentiated carcinoma (SNUC): morphoproteomic-guided treatment paradigm with clinical efficacy. Ansari M; Guo S; Fakhri S; Citardi MJ; Blanco A; Patino M; Buryanek J; Amato R; Karni R; Brown RE Ann Clin Lab Sci; 2013; 43(1):45-53. PubMed ID: 23462605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]